411 related articles for article (PubMed ID: 33896830)
1. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
[TBL] [Abstract][Full Text] [Related]
2. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
3. Expressions of Interleukin-27 in Oral Lichen Planus, Oral Leukoplakia, and Oral Squamous Cell Carcinoma.
Wang QM; Huang XY; Guan WQ
Inflammation; 2022 Jun; 45(3):1023-1038. PubMed ID: 35064378
[TBL] [Abstract][Full Text] [Related]
4. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
5. CircHLA-C: A significantly upregulated circRNA co-existing in oral leukoplakia and oral lichen planus.
Yang J; Song Y; Xu S; Ge S; Haiwen Z
Organogenesis; 2023 Dec; 19(1):2234504. PubMed ID: 37531467
[TBL] [Abstract][Full Text] [Related]
6. Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression.
Yang Q; Sun H; Wang X; Yu X; Zhang J; Guo B; Hexige S
J Cell Mol Med; 2020 Jan; 24(2):1179-1188. PubMed ID: 31793175
[TBL] [Abstract][Full Text] [Related]
7. Salivary β2-microglobulin levels in patients with erosive oral lichen planus and squamous cell carcinoma.
Nosratzehi F; Nosratzehi T; Alijani E; Rad SS
BMC Res Notes; 2020 Jun; 13(1):294. PubMed ID: 32552881
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic relevance of salivary microRNA-21, -125a, -31 and -200a levels in patients with oral lichen planus - a short report.
Mehdipour M; Shahidi M; Manifar S; Jafari S; Mashhadi Abbas F; Barati M; Mortazavi H; Shirkhoda M; Farzanegan A; Elmi Rankohi Z
Cell Oncol (Dordr); 2018 Jun; 41(3):329-334. PubMed ID: 29480379
[TBL] [Abstract][Full Text] [Related]
9. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
10. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
[TBL] [Abstract][Full Text] [Related]
11. A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia.
Yan SK; Wei BJ; Lin ZY; Yang Y; Zhou ZT; Zhang WD
Oral Oncol; 2008 May; 44(5):477-83. PubMed ID: 17936673
[TBL] [Abstract][Full Text] [Related]
12. Discrimination of oral squamous cell carcinoma from oral lichen planus by salivary metabolomics.
Ishikawa S; Sugimoto M; Edamatsu K; Sugano A; Kitabatake K; Iino M
Oral Dis; 2020 Jan; 26(1):35-42. PubMed ID: 31602722
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between the quantity of oral mucosal micronucleus cells and cancerization].
Cao J; Liu HW; Liu XS; Jin JQ; Zhang P
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):600-2. PubMed ID: 21844976
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma.
Agha-Hosseini F; Mirzaii-Dizgah I; Farmanbar N; Abdollahi M
J Oral Pathol Med; 2012 Nov; 41(10):736-40. PubMed ID: 22582895
[TBL] [Abstract][Full Text] [Related]
15. Salivary basic fibroblast growth factor in patients with oral squamous cell carcinoma or oral lichen planus.
Gorugantula LM; Rees T; Plemons J; Chen HS; Cheng YS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):215-22. PubMed ID: 22769407
[TBL] [Abstract][Full Text] [Related]
16. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma.
Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414
[TBL] [Abstract][Full Text] [Related]
17. Overestimated risk of transformation in oral lichen planus.
Cai X; Zhang J; Zhang H; Li T
Oral Oncol; 2022 Oct; 133():106025. PubMed ID: 35858493
[TBL] [Abstract][Full Text] [Related]
18. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
19. Serum and salivary levels of lactate dehydrogenase in oral squamous cell carcinoma, oral lichen planus and oral lichenoid reaction.
Gholizadeh N; Alipanahi Ramandi M; Motiee-Langroudi M; Jafari M; Sharouny H; Sheykhbahaei N
BMC Oral Health; 2020 Nov; 20(1):314. PubMed ID: 33167957
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma.
Sun Y; Liu N; Guan X; Wu H; Sun Z; Zeng H
Mediators Inflamm; 2016; 2016():5715719. PubMed ID: 28053372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
